493. Incidence and Characterization of Chronic Active COVID Among Patients Infected with the Novel Coronavirus (COVID-19) Receiving B-cell Depleting Therapies (BCDTs)

BACKGROUND: There have been reports of COVID-19 infection characterized by prolonged viral replication [chronic active COVID-19 (CAC)] among immunocompromised patients, including those receiving B-cell depleting therapies (BCDTs). We aimed to characterize the severity and incidence of CAC among pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kartes, Jacob, Spivak, Emily S, Imlay, Hannah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644725/
http://dx.doi.org/10.1093/ofid/ofab466.692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644725/
http://dx.doi.org/10.1093/ofid/ofab466.692

Ejemplares similares